Gender affirming hormone therapy for individuals with gender dysphoria aged <26 years: a systematic review and meta-analysis
Gender affirming hormone therapy for individuals with gender dysphoria aged <26 years: a systematic review and meta-analysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Gender affirming hormone therapy for individuals with gender dysphoria aged <26 years: a systematic review and meta-analysis have?
Gender affirming hormone therapy for individuals with gender dysphoria aged <26 years: a systematic review and meta-analysis has 28 citations in the OpenAlex counts ScholarIQ stores.
When was Gender affirming hormone therapy for individuals with gender dysphoria aged <26 years: a systematic review and meta-analysis published?
Gender affirming hormone therapy for individuals with gender dysphoria aged <26 years: a systematic review and meta-analysis has 2025 year in the ScholarIQ index.
What is the open-access status of Gender affirming hormone therapy for individuals with gender dysphoria aged <26 years: a systematic review and meta-analysis?
Gender affirming hormone therapy for individuals with gender dysphoria aged <26 years: a systematic review and meta-analysis has hybrid oa status in the ScholarIQ index.
What is the DOI of Gender affirming hormone therapy for individuals with gender dysphoria aged <26 years: a systematic review and meta-analysis?
The DOI for Gender affirming hormone therapy for individuals with gender dysphoria aged <26 years: a systematic review and meta-analysis is on the source record.
What is the PMID of Gender affirming hormone therapy for individuals with gender dysphoria aged <26 years: a systematic review and meta-analysis?
The PMID for Gender affirming hormone therapy for individuals with gender dysphoria aged <26 years: a systematic review and meta-analysis is on the source record.
What is the OpenAlex record for Gender affirming hormone therapy for individuals with gender dysphoria aged <26 years: a systematic review and meta-analysis?
The OpenAlex for Gender affirming hormone therapy for individuals with gender dysphoria aged <26 years: a systematic review and meta-analysis is on the source record.